2018
DOI: 10.1007/s00134-018-5048-5
|View full text |Cite|
|
Sign up to set email alerts
|

External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
49
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 47 publications
(51 citation statements)
references
References 6 publications
2
49
0
Order By: Relevance
“…This allowed us to perform a comparative analysis using various definitions for ARDS. Another strength is the larger number of patients in our study compared with prior published work on lung ultrasound in ARDS [ 11 , 12 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This allowed us to perform a comparative analysis using various definitions for ARDS. Another strength is the larger number of patients in our study compared with prior published work on lung ultrasound in ARDS [ 11 , 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…Apart from a small pilot study [ 11 ] and a recent evaluation of the Kigali Modification [ 12 ], the use of chest radiography versus the use of lung ultrasound for the identification of ARDS has not been systematically studied. It is also unclear how the choice of imaging would affect ARDS identification.…”
Section: Introductionmentioning
confidence: 99%
“…The Kigali modification of the Berlin definitions of ARDS uses pulse oximetry and LUS findings to define the severity of ARDS, and has proven to be an excellent alternative to the Berlin definition, which relies on blood gas analysis and chest X-ray or CT scan findings. 22,23 Supplemental oxygen. In patients with moderate severe COVID-19, supplemental oxygen can be provided using simple nose prongs or face masks with an oxygen flow up to around 5-6 L O 2 /minute.…”
Section: Introductionmentioning
confidence: 99%
“…8 Scores are then summed to a global score that ranges from 0 (i.e., "no abnormalities at all") to 36 (i.e., "consolidations in all regions"). Global LUS scores combined with SpO 2 /FiO 2 in a resourcelimited setting, 9 and with PaO 2 /FiO 2 in a resource-rich setting, 10 showed good performance for diagnosing acute respiratory distress syndrome (ARDS) and for assessing ARDS severity. 11 Of note, current global LUS scores do not include pleural thickening and subpleural abnormalities, which seem often present in COVID-19.…”
mentioning
confidence: 99%